Weiyu Ge

731 total citations
20 papers, 502 citations indexed

About

Weiyu Ge is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Weiyu Ge has authored 20 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Weiyu Ge's work include Pancreatic and Hepatic Oncology Research (9 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Weiyu Ge is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Weiyu Ge collaborates with scholars based in China and Germany. Weiyu Ge's co-authors include Junjian Li, Li Zhu, Hongxia Wang, Gaoda Ju, Zhimin Lu, Yi Chen, Olivier Gires, Jun Liu, Jing Huang and Rongxuan Zhu and has published in prestigious journals such as Nature Communications, Oncogene and Chemical Engineering Journal.

In The Last Decade

Weiyu Ge

20 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiyu Ge China 9 324 181 173 79 64 20 502
Natascha Cremers Germany 11 239 0.7× 137 0.8× 290 1.7× 92 1.2× 63 1.0× 12 516
Hiroki Ueo Japan 13 348 1.1× 206 1.1× 173 1.0× 46 0.6× 57 0.9× 28 501
M. Ángeles Villaronga Spain 17 420 1.3× 162 0.9× 139 0.8× 41 0.5× 74 1.2× 28 577
Zhihai Peng China 8 476 1.5× 192 1.1× 146 0.8× 73 0.9× 73 1.1× 15 616
Danielle L. Jernigan United States 9 315 1.0× 143 0.8× 225 1.3× 76 1.0× 103 1.6× 11 553
Honggang Yu China 16 400 1.2× 225 1.2× 152 0.9× 83 1.1× 72 1.1× 22 605
Fumihiko Kakizaki Japan 9 322 1.0× 137 0.8× 215 1.2× 71 0.9× 35 0.5× 17 517
Jian Xie China 10 365 1.1× 234 1.3× 154 0.9× 67 0.8× 56 0.9× 19 512
Guoxin Mao China 17 511 1.6× 221 1.2× 189 1.1× 81 1.0× 83 1.3× 35 655
Huizhi Sun China 16 478 1.5× 313 1.7× 188 1.1× 76 1.0× 72 1.1× 23 641

Countries citing papers authored by Weiyu Ge

Since Specialization
Citations

This map shows the geographic impact of Weiyu Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyu Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyu Ge more than expected).

Fields of papers citing papers by Weiyu Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyu Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyu Ge. The network helps show where Weiyu Ge may publish in the future.

Co-authorship network of co-authors of Weiyu Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyu Ge. A scholar is included among the top collaborators of Weiyu Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyu Ge. Weiyu Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Haiyan, Yang Sun, Jingyu Ma, et al.. (2025). CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment. Journal for ImmunoTherapy of Cancer. 13(1). e010029–e010029. 1 indexed citations
2.
Ge, Weiyu, et al.. (2025). Pyridine-based ionic liquid with Sn site as an efficient catalyst for CO2 cycloaddition. Chemical Engineering Journal. 514. 163303–163303. 1 indexed citations
3.
Su, Juan, Weiyu Ge, Yan Su, et al.. (2025). Dual-colorimetric amplification biosensor based on GNPs and G-quadruplex/hemin DNAzyme for multiplexed microRNAs. Talanta. 297(Pt A). 128682–128682. 1 indexed citations
4.
Ge, Weiyu, Y Wang, Ming Quan, et al.. (2024). Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib. Molecular Cancer. 23(1). 48–48. 23 indexed citations
5.
Ge, Weiyu, Yue Ming, Tianhao Zhou, et al.. (2023). PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells. Cancer Letters. 558. 216095–216095. 44 indexed citations
6.
Li, Shumin, Yue Ming, Haiyan Xu, et al.. (2023). Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Cancer Letters. 564. 216206–216206. 43 indexed citations
7.
Ge, Weiyu, Jiujie Cui, Xiaofei Zhang, et al.. (2023). Cuproptosis‐related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients. IET Systems Biology. 17(4). 174–186. 6 indexed citations
8.
Ge, Weiyu, Tiebo Mao, Xiaofei Zhang, et al.. (2022). Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer. Disease Markers. 2022. 1–22. 10 indexed citations
9.
Lu, Xiaoqing, Liwei An, Guangjian Fan, et al.. (2022). EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription. Cell Research. 32(4). 359–374. 54 indexed citations
10.
Ge, Weiyu, Kexuan Wang, Tiebo Mao, et al.. (2022). Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Frontiers in Cell and Developmental Biology. 10. 942225–942225. 6 indexed citations
11.
Ge, Weiyu, Yongchao Wang, Yanling Wang, et al.. (2022). A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer. Frontiers in Cell and Developmental Biology. 10. 1001606–1001606. 3 indexed citations
12.
Ge, Weiyu, Ruirong Lin, Tianhao Zhou, et al.. (2022). PLA2G2A Cancer-Associated Fibroblasts Mediate Pancreatic Cancer Immune Escape Via Impeding Antitumor Immune Response of CD8 Cytotoxic T Cells. SSRN Electronic Journal. 7 indexed citations
13.
Mao, Tiebo, Xiaofei Zhang, Haiyan Xu, et al.. (2022). HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53. Cancer Cell International. 22(1). 380–380. 4 indexed citations
14.
Ge, Weiyu, Jingyu Ma, Tiebo Mao, et al.. (2022). Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer. Frontiers in Oncology. 12. 890715–890715. 2 indexed citations
15.
Ge, Weiyu, Yue Ming, Yanling Wang, et al.. (2022). A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer. International Journal of Molecular Sciences. 24(1). 156–156. 4 indexed citations
16.
Zhang, Xiaofei, Tiebo Mao, Haiyan Xu, et al.. (2022). Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer. Aging. 14(8). 3597–3606. 2 indexed citations
17.
Li, Junjian, Xiaoliang Chen, Li Zhu, et al.. (2021). SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer. Oncogene. 40(30). 4884–4893. 31 indexed citations
18.
Ge, Weiyu, et al.. (2020). <p>ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics</p>. OncoTargets and Therapy. Volume 13. 2843–2854. 8 indexed citations
19.
Zhu, Rongxuan, Olivier Gires, Li Zhu, et al.. (2019). TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling. Nature Communications. 10(1). 2863–2863. 141 indexed citations
20.
Chen, Y, Yongtao Xiao, Weiyu Ge, et al.. (2013). miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death and Disease. 4(3). e541–e541. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026